Rafferty Asset Management
CVAC

Rafferty Asset Management’s CureVac CVAC Stock Holding History

Rafferty Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-72,148
Closed -$503K – 1105
2023
Q1 		$503K Sell
72,148
-10,686
-13% -$93.2K ﹤0.01% 932
2022
Q4 		$499K Buy
82,834
+2,155
+3% +$15.9K ﹤0.01% 897
2022
Q3 		$636K Buy
80,679
+1,932
+2% +$22.5K 0.01% 800
2022
Q2 		$1.07M Buy
+78,747
New +$1.3M 0.01% 621

Other funds holding CVAC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Rafferty Asset Management's CVAC Position: Q2 2023 in Review

Rafferty Asset Management sold out of CureVac (CVAC) in Q2 2023, closing a stake of 72,148 shares — an estimated $503K sold.

Rafferty Asset Management first reported a position in CVAC in Q2 2022 and held it in 4 quarters. The position peaked at $1.07M in Q2 2022. 88 funds tracked by Wall St. Rank hold CVAC as of Q2 2023.

  • Rafferty Asset Management reported no remaining CureVac position as of Q2 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 72,148 CureVac shares in Q2 2023, an estimated $503K.
  • Rafferty Asset Management first reported a position in CureVac in Q2 2022 and held it in 4 quarters.
  • Rafferty Asset Management's CureVac position peaked at $1.07M in Q2 2022.
  • 88 funds tracked by Wall St. Rank held CureVac as of Q2 2023.

Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.